287 related articles for article (PubMed ID: 2374609)
1. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.
Border WA; Okuda S; Languino LR; Sporn MB; Ruoslahti E
Nature; 1990 Jul; 346(6282):371-4. PubMed ID: 2374609
[TBL] [Abstract][Full Text] [Related]
2. Role of TGF-beta 1 in experimental glomerulonephritis.
Border WA; Okuda S; Nakamura T; Languino LR; Ruoslahti E
Ciba Found Symp; 1991; 157():178-89; discussion 189-93. PubMed ID: 2070683
[TBL] [Abstract][Full Text] [Related]
3. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis.
Kagami S; Border WA; Ruoslahti E; Noble NA
Lab Invest; 1993 Jul; 69(1):68-76. PubMed ID: 8331901
[TBL] [Abstract][Full Text] [Related]
4. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
Border WA; Noble NA; Yamamoto T; Harper JR; Yamaguchi Yu; Pierschbacher MD; Ruoslahti E
Nature; 1992 Nov; 360(6402):361-4. PubMed ID: 1280332
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
Okuda S; Languino LR; Ruoslahti E; Border WA
J Clin Invest; 1990 Aug; 86(2):453-62. PubMed ID: 2200803
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Huijun W; Long C; Zhigang Z; Feng J; Muyi G
Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.
Border WA; Ruoslahti E
Cell Differ Dev; 1990 Dec; 32(3):425-31. PubMed ID: 2099240
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.
Kopp JB; Factor VM; Mozes M; Nagy P; Sanderson N; Böttinger EP; Klotman PE; Thorgeirsson SS
Lab Invest; 1996 Jun; 74(6):991-1003. PubMed ID: 8667617
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
11. Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis.
Gaedeke J; Boehler T; Budde K; Neumayer HH; Peters H
Nephrol Dial Transplant; 2005 Feb; 20(2):319-28. PubMed ID: 15673690
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.
Yoshioka K; Takemura T; Murakami K; Okada M; Hino S; Miyamoto H; Maki S
Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250
[TBL] [Abstract][Full Text] [Related]
13. Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis.
Shimizu M; Kondo S; Urushihara M; Takamatsu M; Kanemoto K; Nagata M; Kagami S
Nephrol Dial Transplant; 2006 Sep; 21(9):2380-90. PubMed ID: 16728424
[TBL] [Abstract][Full Text] [Related]
14. [Transforming growth factor-beta: a new approach to the pathogenesis of glomerulonephritis and glomerulosclerosis].
Witowski J; Knapowski J
Przegl Lek; 1995; 52(9):467-73. PubMed ID: 8834649
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis.
Narita I; Border WA; Ketteler M; Noble NA
Lab Invest; 1995 Jan; 72(1):17-24. PubMed ID: 7837786
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.
Bruijn JA; Roos A; de Geus B; de Heer E
J Lab Clin Med; 1994 Jan; 123(1):34-47. PubMed ID: 8288959
[TBL] [Abstract][Full Text] [Related]
17. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
[TBL] [Abstract][Full Text] [Related]
18. Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis.
Okuda S; Nakamura T; Yamamoto T; Ruoslahti E; Border WA
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9765-9. PubMed ID: 1946401
[TBL] [Abstract][Full Text] [Related]
19. Cytokines in kidney disease: the role of transforming growth factor-beta.
Border WA; Noble NA
Am J Kidney Dis; 1993 Jul; 22(1):105-13. PubMed ID: 8322771
[TBL] [Abstract][Full Text] [Related]
20. Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis.
Tang WW; Feng L; Loskutoff DJ; Wilson CB
Nephron; 2000 Jan; 84(1):40-8. PubMed ID: 10644907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
